Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

Research data set uoadl:3405734 12 Read counter

Unit:
Faculty of Medicine
Title:
Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.
Languages of Item:
English
Creation year:
2024
Authors:
Dimitrios Basoulis1*, Elpida Mastrogianni2, Georgios Karamanakos3, Aikaterini Gkoufa1, Vasiliki E. Georgakopou-lou1, Sotiria Makrodimitri1, Maria N. Gamaletsou1, Antonios Markogiannkis4, Nikolaos V. Sipsas1
Keywords:
covid
Main subject category:
Health Sciences